Assertio Holdings, Inc - Strategy, SWOT and Corporate Finance Report
Summary
Assertio Holdings, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Assertio Holdings Inc (Assertio and ‘the company’) is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Assertio primary markets INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), SPRIX (ketorolac tromethamine) and Nasal Spray, Zipsor (diclofenac potassium) Liquid filled capsules. These drugs are used for the treatment of rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder, acute gouty arthritis, migraine attacks in adults, moderately severe pain, and mild-to-moderate pain in adults. The company sells its products to wholesale distributors and retail pharmacies. Assertio is headquartered in Lake Forest, Illinois, the US
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook